key: cord-0841822-j8d7g5i1
authors: Kalyanaraman, Balaraman
title: Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity?
date: 2020-09-15
journal: Redox Biol
DOI: 10.1016/j.redox.2020.101721
sha: e10b3e9d3b3376c37fa5f91cc0d7b341788f9072
doc_id: 841822
cord_uid: j8d7g5i1

This review focuses on the hypothetical mechanisms for enhanced vulnerability of African Americans to SARS-CoV-2 infection, COVID-19 severity, and increased deaths. A disproportionately higher number of African Americans are afflicted with autoimmune and inflammatory diseases (e.g., diabetes, hypertension, obesity), and SARS-CoV-2 has helped expose these health disparities. Several factors including socioeconomic status, inferior health care, and work circumstances contribute to these disparities. Identifying potential inflammatory biomarkers and decreasing basal levels in high-risk individuals with comorbidities through preventive measures is critical. Immune cells, particularly neutrophils, protect us against pathogens (bacteria, fungi, and viruses) through increased generation of free radicals or oxidants and neutrophil extracellular traps (NETs) that ensnare pathogens, killing them extracellularly. However, continued generation of NETs coupled with the lack of prompt removal pose danger to host cells. NET levels are increased during pro-inflammatory diseases. COVID-19 patients exhibit elevated NET levels, depending upon disease severity. Conceivably, high-risk individuals with elevated basal NET levels would exhibit hyper-inflammation when infected with SARS-CoV-2, amplifying disease severity and deaths. Drugs inhibiting oxidant formation and vitamin supplements decreased NET formation in mice models of inflammation. Thus, preventive treatments lowering NET levels and inflammation in high-risk individuals could mitigate SARS-CoV-2-induced complications and decrease mortality.

NETosis is a form of cell death that is distinctly different from apoptosis or necrosis (15, 16) .

Following an intracellular oxidative burst in response to a bacterial, fungal, or viral infection, neutrophils extrude DNA and antimicrobial proteins during NETosis into the extracellular space, forming a net-like structure, or NETs (similar to a spider web), to trap and kill invading pathogens, including bacteria, fungi, and viruses ( Fig. 3 ) (15) (16) (17) . Structurally, NETs consist of extracellular DNA decorated with histones, cytosolic proteins, and granular proteins; neutrophil elastase; and oxidative enzymes, Nox2, MPO, and NOS (18, 19) (Fig. 3) . Histones are positively charged and form a nucleosome with chromatin. Neutrophil elastase, a serine protease, translocates to the nucleus and instigates NET formation. NET formation is triggered by innate immunity receptors activating Nox2 and/or mitochondria that subsequently activate MPO, neutrophil elastase, and a calcium-dependent protein-arginine deiminase type 4 (PAD4). PAD4 citrullinates histones and decreases the net positive charge by converting the positively charged arginine to the neutral citrulline, promoting chromatin decondensation (20) . Neutrophils derived from patients with chronic granulomatous disease with mutations in Nox2, which does not generate O 2 •-, failed to induce NET formation (21) . Both Nox2 and MPO are implicated in NET formation in plasma isolated from patients with autoimmune conditions (22) . The 8-hydroxy deoxyguanosine (8-OHdG)-enriched DNA present in NETs binds to a transmembrane protein on tumor cells and facilitates their metastatic potential, as discussed later (23, 24) .

Despite its antimicrobial effects, the excessive accumulation of NET causes damage to the host by inducing pro-inflammatory mechanisms (25, 26) . The timely removal of NETs is crucial for preventing self-antigens (27) . Degradation of NETs in ischemia/reperfusion-challenged intestinal tissue with deoxyribonuclease 1 (DNase 1) is proposed as an effective treatment against intestinal ischemia/reperfusion injury (28) . Acute and chronic inflammation and autoimmune J o u r n a l P r e -p r o o f 6 disorders are associated with enhanced NET levels (17) . A decreased ability to degrade NETs is pronounced in systemic lupus erythematosus lupus (SLE) patients with antiphospholipid syndrome (29-32) and nephritis (27) , and degradation of NETs is impaired by the presence of autoantibodies, increasing the risk of thrombosis.

Enhanced release of NETs was reported to occur in severe cases of COVID-19 (33, 34) . Sera from COVID-19 patients revealed elevated levels of extracellular DNA (cell-free DNA), and two specific markers of NETs: MPO-DNA and citrullinated histone H3. The levels of cell-free DNA showed a strong correlation with other markers of inflammation (e.g., C-reactive protein, Ddimer). Both cell-free DNA and MPO-DNA were much higher in patients on mechanical ventilation as compared with patients breathing room air. Another interesting finding of this study (17) is that sera from COVID-19 patents triggered NET release from control neutrophils in vitro, indicating that circulating NETs could be used to predict the extent of disease severity.

NETs stimulated immunothrombosis in COVID-19 patients and were suggested as suitable therapeutic targets for mitigating prothrombotic complications in COVID-19 patients (35) .

After entering the respiratory tract, SARS-CoV-2 uses a spike protein and latches onto the angiotensin-converting enzyme 2 (ACE2) receptor present on the surface of the cell membrane, fuses into the lung cell membrane, and begins replicating ( Fig. 4) (36) . A major function of ACE2 is to convert angiotensin II (AT-II) that is vasoconstrictive to angiotensin 1,7 (AT-1,7) that exerts vasodilatory effects. AT-II activates O 2

•whereas AT-1,7 decreases O 2 •in vascular cells 7 inhibitors nor angiotensin receptor blockers were associated with increased mortality in COVID-19 patients (44, 45) .

COVID-19 patients who were admitted into the intensive care unit showed elevated levels of cytokines as compared with those who were not admitted. During the early stages of this pandemic, many patients on ventilators developed respiratory illness and died. More recently, due to antiviral drugs (e.g., remdesivir) and anti-inflammatory steroids (e.g., dexamethasone), respiratory-illness-related deaths have dramatically decreased. Remdesivir, a nucleoside analog that mimics a viral RNA component, inhibits the RNA polymerase enzyme that SARS-CoV-2 uses for replication (46) . Dexamethasone, an FDA-approved immunosuppressive steroid that has been used in the clinic for over 50 years, prevented mortality in seriously ill COVID-19

patients (47) . In response to SARS-CoV-2 infection, the immune system is activated through recruitment of T-cells, macrophages, and dendritic cells. These immune cells secrete molecules, cytokines and chemokines, to combat the viral infection. The "cytokine storm" refers to an uncontrolled, hyper-activation of immune cells, cytokines (IL-6), and chemokines (CXCL10). NETs induce pro-inflammatory cytokines that further stimulate NET and cause a "feedback" snowballing effect (48) . Drugs decreasing the NET levels have been shown to prevent COVID-19 associated cytokine release (49) . 

The link between oxidative stress and endothelial dysfunction is well established (52) . In an animal model of obesity, increased NET formation was shown to be associated with inflammation and endothelial dysfunction (53) . Prevention of NET formation with 2chloroamidine, an inhibitor of peptidylarginine deaminase 4, that inhibits the citrullination of histone decreased obesity-related endothelial dysfunction and inflammation (53) . In another study, it was reported that NET levels did not affect the onset of obesity or adipose tissue inflammation but may affect obesity-induced pathologies (54) . Severe obesity in patients was shown to be associated with enhanced NET generation (55) . Obesity is proposed as a major risk factor for increased prevalence, severity, and lethality of COVID-19 (56) . Inhibiting NET in obese individuals would be a promising therapeutic strategy.

Hypertension (increased blood pressure) is more prevalent in African Americans, and obesity is a major contributing factor (57) . Emerging research reveals a new role for neutrophils in hypertension (58) . The presence of a salt-sensitive gene that regulates vascular resistance and renal sodium transport in African Americans increases the risk of developing high blood pressure (59). This particular gene is a variant of the angiotensin-converting enzyme that enhances the release of AT-II, a vasoconstrictor. Enhanced formation of oxidants and NETs J o u r n a l P r e -p r o o f 9 were shown to contribute to elevated blood pressure in spontaneously hypertensive rats (60) .

Studies implicate a role for enhanced angiotensin II and activation of Nox2 and NETosis in arterial hypertension (60) (61) (62) . African Americans with hypertension exhibit decreased activity of antioxidant enzymes (63) .

In contrast to initial thinking that COVID-19 predominantly damages the lungs, recent research shows that the virus causes inflammation in the heart, affects heart function, and diminishes oxygen supply to the heart muscle (64) . People with preexisting heart conditions are at increased risk for developing severe heart problems. SARS-CoV-2 presumably enters through the ACE2 receptors present in the heart and directly attacks the heart cells, causing an extreme inflammatory reaction that induces a cytokine storm (e.g., IL-6,7,22 and CXCL10) and can even trigger a heart attack (65) . NETs were proposed to play a primary role in acute myocardial infarction caused by the rupture of a coronary atherosclerotic plaque followed by a thrombus artery occlusion (66,67). Impaired DNase 1-mediated degradation of NET is associated with excessive microvascular thrombosis (68). Lack of removal of NETs over a long period of time induces collagen deposition, increased fibrosis, and heart failure (69) .

Diabetes is a key risk factor for developing severe COVID-19, and COVID-19 patients with this underlying condition are more likely to die of respiratory and cardiovascular complications (70, 71) . Diabetes is marked by chronic inflammation, endothelial dysfunction, and other cardiovascular complications. The connection between high glucose or hyperglycemia-induced NET formation and the NADPH oxidase pathway and diabetic retinopathy is strong (72) (73) (74) (75) .

NET levels and biomarkers of NETosis were increased in the serum of diabetics (72) . Increased

NETs and pro-inflammatory cytokines were detected in type 2 diabetes mellitus patients (73- J o u r n a l P r e -p r o o f 10 75) . Impaired wound healing in patients with type 2 diabetes was attributed to increased NET levels (76) . SARS-CoV-2 has been found to destroy insulin-producing cells, inducing conditions in COVID-19 patients similar to those in patients with type 1 diabetes (77, 78) . A recent report suggests that elevated glucose levels enhanced SARS-CoV-2 infection and viral load in patients with uncontrolled diabetes via a glycolytic mechanism (79) . Enhanced generation of mitochondrial O 2 •was thought to be responsible for SARS-CoV-2 replication and for elevated cytokine production in monocytes present in diabetic patients.

Sickle cell disease (SCD) is an inherited autosomal recessive disorder that is predominantly seen in African Americans (50). The distorted shape of sickle red blood cells makes them more prone to hemolysis. SCD is characterized by chronic hemolysis with elevated levels of heme and cell-free hemoglobin. Neutrophilia is a major characteristic of SCD. In a humanized SCD mouse model, enhanced levels of NET were detected in the lungs and in plasma (80) . This study also revealed that heme present in the plasma stimulates in vitro and in vivo NET formation in SCD mice (81) . Increasing or decreasing plasma heme concentrations was shown to induce or prevent NETosis in SCD, respectively. Treating SCD mice with hemopexin to scavenge free heme reduced NET formation (81) . Results from these studies show that free iron is involved in NET formation and treatment of SCD plasma, with the iron chelator deferoxamine or the iron binding apotransferrin effectively inhibiting NET release (82) . The commonly used and FDA-approved drug hydroxyurea, which induces fetal hemoglobin and reduces neutrophil count, did not decrease the NET activity and pro-inflammatory effects associated with SCD (83).

SLE is an autoimmune disease characterized by generation of autoantibodies directed against attenuated the severity of lupus in the mouse model (86, 87) . It was suggested that Mito-Q could inhibit type 1 interferon (IFN-1), upstream of O 2 •production (88) . Mito-Q also inhibited IFN-1 that is a byproduct of NETosis (88). Immune system activation by mitochondria was recently reported (89) . Post-translational protein citrullination mediated by the nuclear enzyme PAD4 has also been implicated in autoimmune disorders (e.g., rheumatoid arthritis) in African Americans (90) .

African Americans are at higher risk of developing chronic obstructive pulmonary disease (COPD) and asthma, diseases that obstruct airways and make breathing difficult. African

American women (also non-smokers) in particular are vulnerable to developing COPD (91).

Enhanced airway neutrophilic inflammation is a characteristic hallmark of COPD. Stable COPD patients exhibit enhanced NET formation and extracellular DNA in sputum (92) . Reports suggest that oxidants enhance NET formation in airway neutrophils; in addition, it was reported J o u r n a l P r e -p r o o f 12 that chemokine CXCL8 regulates NET formation in COPD patients (48) . CXCR2 antagonist AZD5069 decreased NETosis and NET levels in COPD-derived neutrophils (48) . Studies show that NET formation correlates with the severity of airflow limitation (91). Decreasing NET levels in COPD and asthmatic patients may be beneficial to mitigate chronic airway inflammation.

The prevalence of Alzheimer's disease (AD) in African Americans is two-to threefold higher than in Caucasians, and older African Americans are disproportionately affected by the disease 

Metastasis of breast cancer, a leading cause of death, occurs at high rates in African American women (106) . Increased levels of NETs were identified in the metastatic lesions (23, 24) . A recent study showed that NETosis and enhanced NET formation in the distant organs preceded cancer metastasis, suggesting that NETs in blood could be used as a predictive biomarker of metastasis (23). 8-OHdG, a characteristic hallmark of NET-DNA, is an extracellular DNA sensor. The transmembrane protein CDC25 interacts with NET-DNA, supporting the proliferation of metastatic cells (23, 24) . Other markers of NETosis and serum NET levels (e.g., MPO-DNA) were found to be higher in breast cancer patients with liver metastases (23).

Therapeutic targeting CDC25 and mitigating NETs in cancer patients may be an effective approach for preventing cancer metastasis (23, 24) . Targeting NETosis in the tumor immune microenvironment was proposed as a promising strategy to inhibit metastatic progression (23, 24, 107) .

Early on, COVID-19 was thought to be primarily a lung-related problem resulting in acute respiratory disease syndrome. Elevated levels of D-dimer and procoagulants such as von

Willebrand factor (VWF), a multimeric glycoprotein, and coagulation factor VIII (FVIII) were detected in COVID-19 patients after stroke. These patients had enhanced blood clots or microthrombosis mediated by VWF and FVIII and were treated with unfractured heparin and other VWF-modifying agents.

The presence of enhanced levels of high-molecular-weight multimers of VWF is an established risk factor for arterial thrombosis (108) .The virus binds to endothelial cells and induces J o u r n a l P r e -p r o o f 14 inflammation through inactivation of the ACE2 enzyme. ACE2 inactivation increases AT-II, a vasoconstrictor, as it is metabolized to AT-1,7, which causes vasodilation (Fig. 4) . ACE2

inactivation and an increase in AT-II results in enhanced O 2 •formation from Nox2 and inflammation of the sub-endothelium. During this process, procoagulants (VWF and FVIII) are released.

Basic research strongly supports that drugs mitigating NET levels in diseases decrease inflammation (109) . We hypothesize that mitigation of NETs in African Americans with underlying medical conditions would improve their health and decrease the severity of COVID-19, thus saving lives.

FDA-approved drugs decrease NET and inflammatory biomarkers (110). Metformin, one of the most widely used antidiabetic drugs, decreased NET formation in SLE patients (111) . 5aminiosalicylic acid (mesalamine), which is widely used to treat inflammatory bowel diseases, inhibits NET formation (112) . Dipyridamole is an FDA-approved drug that activates adenosine A2A receptors and inhibits NETs (113) . Recently, an antibody therapy using the anti-citrullinated protein antibody against NET has been reported (114) .

Hydroxychloroquine and chloroquine are FDA-approved drugs for treating malaria, lupus, and rheumatoid arthritis. Hydroxychloroquine and chloroquine inhibit NET formation in murine models of pancreatitis and ischemia/reperfusion injury (115) (116) (117) . However, use of hydroxychloroquine and chloroquine in COVID-19 patients causes serious heart rhythm problems (118) . Recent studies have concluded that neither hydroxychloroquine nor chloroquine, either alone or in combination with azithromycin, is an effective antiviral drug against SARS-CoV-2 (118) (119) (120) . A randomized, double-blind, placebo-controlled trial showed J o u r n a l P r e -p r o o f 15 that the prophylactic use of hydroxychloroquine did not prevent symptomatic infection after SARS-CoV-2 exposure (121) . Investigators also reported that hydroxychloroquine decreased COVID-19 associated mortality in a multi-center retrospective study (122) . Additional 

Glutathione Glutathione (GSH), a tripeptide consisting of cysteine, glycine, and glutamate, is one of the most abundant cellular antioxidants involved in the removal of H 2 O 2 and activation of key enzymes (thioredoxins, peroxiredoxins, and glutathione peroxidases). N-acetyl cysteine (NAC) is an intracellular precursor of GSH, and its protective mechanism is linked to reduction of disulfides and regeneration of GSH. Recent clinical reports hypothesized that GSH deficiency is a plausible cause of increased susceptibility to SARS-CoV-2 infection in older people and in those with preexisting medical conditions (e.g., diabetes and cardiovascular and respiratory diseases) (123) . GSH lowers viral load and viral infection; inhibits oxidative stress, inflammation, proinflammatory cytokines (e.g., IL-6, IL-8, and TNF-α), and thrombosis; and potentially boosts immune function (123, 124) . Inadequate nutrition and insufficient consumption of fresh fruits and vegetables could contribute to endogenous GSH deficiency. GSH therapy has been effectively used to alleviate dyspnea in COVID-19 patients (125) . Prior to supplementation therapy, the basal levels of GSH should be determined.

NAC, an FDA-approved mucolytic drug for chronic obstructive lung disease and acetaminophen toxicity, is currently undergoing clinical trials in COVID-19 patients (126) . NET formation induced by O 2 •promotes thrombosis (127) . NAC can act as an anticoagulant and exert a thrombolytic effect (127) . NAC was found to block NETosis in vitro (128) . Although a multitude of publications claim that NAC acts as an antioxidant by scavenging the O 2 •anion, the collective opinion of experts in the areas of oxidative biology and free radical chemistry is that NAC does not exert protection against oxidative stress by directly scavenging O 2 •or H 2 O 2 (129) . NAC reduces the disulfide bonds (-S-S-) to sulfhydryl groups (-SH). Thus, NAC can increase intracellular GSH levels by reducing glutathione disulfide. The VWF protein forms large multimers through disulfide cross-linking, and microvascular thrombosis is caused by aggregation of platelets due to binding to VWF multimers (130) . NAC alters VWF binding through a reduction of the intrachain disulfide bond and a decrease in the number of VWF multimers (130, 131) . Figure 5 illustrates the plausible mechanism by which NAC might induce platelet disaggregation by reducing the -S-S-bond and decreasing VWF multimers. Vitamin C (ascorbic acid) is an essential nutrient that is acquired from intake of fruits and vegetables or from nutritional supplements. Vitamin C deficiency results in oxidative stress, inflammation, and compromised immune function. Intracellular concentration of ascorbate can be significantly increased when supplemented with dehydroascorbate, the oxidized form of ascorbate (132) . The antioxidant mechanism of ascorbic acid is important for the antimicrobial function of neutrophils (132, 133) . Ascorbate supplementation decreased NET formation in activated neutrophils. Ascorbate supplementation protects against enhanced oxidative stress induced by inflammatory and autoimmune conditions (133) .

Vitamin D deficiency, also known as hypovitaminosis D, is associated with several chronic diseases (e.g., asthma and respiratory disorders) and negatively affects immune function and response. Under these conditions, it is essential to increase the levels of vitamin D through appropriate supplementation. Vitamin D supplementation enhances the innate immune system and reportedly prevents immune system overactivation. Investigators reported a significant correlation between vitamin D deficiency, cytokine storm, and increased COVID-19 mortality 

Recent high-throughput studies discovered a novel class of vanilloids as effective inhibitors of NET formation (138) . The vanilloids capsaicin, dihydrocapsaicin, and resiniferatoxin are natural products that contain the vanillyl moiety (4-hydroxy-3-methoxybenzyl). Capsaicin and dihydrocapsaicin, well known agonists of the TRPV1 (transient receptor potential vanilloid 1)

receptor, are believed to exert their effects via downregulation of NF-κB signaling (138) .

Published reports suggest that compounds inhibiting the mitochondrial respiratory chain inhibit neutrophil activation and oxidative burst (139, 140) . Mitochondrial complex I inhibitors, rotenone and metformin, significantly inhibit the recruitment of neutrophils in a lipopolysaccharide-induced lung inflammation mouse model (141) . Using a neutrophil-specific knockout zebrafish model, the first in vivo evidence was provided for mitochondrial regulation of neutrophil function (142) .

Primary neutrophils depend on mitochondrial membrane potential for chemotaxis. Proper functioning of the mitochondrial electron transport chain is required for neutrophil motility to occur (142) . Perturbation of mitochondrial function was shown to greatly decrease the antimicrobial potency of inflammatory neutrophils (140) . However, the role of mitochondria in oxidative burst induced by neutrophils is questionable; it was previously demonstrated that cyanide inhibited the macrophage/monocyte respiratory burst but not the neutrophil-generated (145) . Mito-Q, co-enzyme Q conjugated to the triphenylphosphonium moiety, decreased NET formation in a lupus mouse model (88) . Mito-Q treatment of SARS-CoV-2-infected monocytes from diabetics decreased viral replication and cytokine upregulation (79) . Figure 6 shows the chemical structures of selected drugs that target mitochondria and inhibit Nox2 activity and inflammation. These and related drugs are promising candidates for mitigation of NETs (146) .

Other mechanisms contribute to oxidative stress in COVID-19 that have not been discussed here. One of the major pathways regulating cellular oxidant balance is the transcription factor, nuclear factor erythroid 2-related factor (Nrf2) (147, 148 

White House Coronavirus Task Force Press Briefing

Experienced discrimination and racial differences in leukocyte gene expression

Characteristics of Persons Who Died with COVID-19 -United States

Race, socioeconomic status, and health. The added effects of racism and discrimination

COVID-19 and African Americans

COVID-19 exacerbating inequalities in the US

2020) Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic -United States

COVID-19 State, T., Local, and Territorial Response Team. (2020) Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19?

Oxygen-dependent microbial killing by phagocytes (first of two parts)

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

Neutrophil extracellular traps kill bacteria

Beneficial suicide: why neutrophils die to make NETs

NETosis: how vital is it?

Extracellular DNA NET-Works With Dire Consequences for Health

Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps

New Aspects of the Biology of Neutrophil Extracellular Traps

Histone deimination as a response to inflammatory stimuli in neutrophils

Does Pioglitazone Lead to Neutrophil Extracellular Traps Formation in

Chronic Granulomatous Disease Patients? Front Immunol 10

Distinguishing NET subtypes

DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25

Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects

Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis

The Role of NETosis in Systemic Lupus Erythematosus

NET formation differs in SLE and vasculitis

2020) Neutrophil extracellular traps in COVID-19

The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?

Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19

Acute Respiratory Distress Syndrome

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Angiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways

Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling

Increases the Severity of the Lung Disease -A Systematic Review

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2

Mas axis and oxidative stress in cardiovascular disease

System Blockers and the Risk of Covid-19

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

Coronavirus breakthrough: dexamethasone is first drug shown to save lives

Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils

N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome

Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation

Oxidative stress and endothelial dysfunction: therapeutic implications

Inhibition of NET Release Fails to Reduce Adipose Tissue Inflammation in Mice

Increased plasmatic NETs by-products in patients in severe obesity

Obesity -a risk factor for increased COVID-19 prevalence, severity and lethality (Review)

Targeting neutrophil: new approach against hypertensive cardiac remodeling?

Genetics of

Hypertension in African Americans and Others of African Descent

Abstract P1126: Neutrophil Extracellular Traps: New Players in Hypertension

NOX2-derived reactive oxygen species in immune cells exacerbates salt-sensitive hypertension

P149Angiotensin-II enhances neutrophil extracellular trap formation in an AT1R and NADPH oxidase-dependent manner

Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension

Neutrophil Extracellular Traps Participate in Cardiovascular Diseases

COVID-19 and Cardiovascular Disease

2020) Neutrophil Extracellular Traps and Cardiovascular Diseases: An Update

Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies

The Science Underlying COVID-19: Implications for the Cardiovascular System

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Challenging role of neutrophil extracellular traps in vascular complications of diabetes mellitus

Hyperglycemia Induces Neutrophil Extracellular Traps Formation Through an NADPH Oxidase

NETosis is induced by high glucose and associated with type 2 diabetes

Evaluation of Circulating Markers of Neutrophil Extracellular Trap (NET) Formation as Risk Factors for Diabetic Retinopathy in a Case-Control Association Study

NETosis before and after Hyperglycemic Control in Type

Diabetes primes neutrophils to undergo NETosis, which impairs wound healing

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv 2020

New-Onset Diabetes in Covid-19

Elevated glucose levels favor SARS-CoV-2 infection

Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease

Heme-Induced Neutrophil Extracellular Traps (NETs) Formation Contributes To Sickle Cell Disease Pathogenesis

Free Iron in Sera of Patients with Sickle Cell Disease Contributes to the Release of Neutrophil Extracellular Traps

Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease

Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies

Removal of Circulating Neutrophil Extracellular Trap Components With an Immobilized Polymyxin B Filter: A Preliminary Study

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease

At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases

Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice

Basic mechanism of immune system activation by mitochondria

Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans

Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease

African-Americans and Alzheimer's Disease: The Silent Epidemic

Alzheimer's Disease Facts and Figures

Alzheimer's disease in African Americans: risk factors and challenges for the future

The role of neutrophil granule proteins in neuroinflammation and Alzheimer's disease

Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin

Alzheimer's Disease

The Brain Entangled: The Contribution of Neutrophil Extracellular Traps to the Diseases of the Central Nervous System

Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase

Stroke Knowledge in African Americans: A Narrative Review

Neutrophil extracellular traps in ischemic stroke thrombi

Neutrophil extracellular traps are increased in patients with acute ischemic stroke: prognostic significance

Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke

Publisher Correction to: Acta Neuropathologica Communications

Racial disparities in the development of breast cancer metastases among older women: a multilevel study

Understanding the tumor immune microenvironment (TIME) for effective therapy

Thrombolytic Potential of N-Acetylcysteine

Mechanisms and disease relevance of neutrophil extracellular trap formation

Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases

Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proofof-Concept Trial of Metformin

Flavonoids and 5-aminosalicylic acid inhibit the formation of neutrophil extracellular traps

Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome

Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases

Enhanced Neutrophil Extracellular Trap Formation in Acute Pancreatitis Contributes to Disease Severity and Is Reduced by Chloroquine

Hydroxychloroquine inhibiting neutrophil extracellular trap formation alleviates hepatic ischemia/reperfusion injury by blocking TLR9 in mice

Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients

Role of glutathione in immunity and inflammation in the lung

Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases

N-acetylcysteine: A rapid review of the evidence for effectiveness in treating COVID-19

Extracellular DNA traps promote thrombosis

N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm

Unraveling the biological roles of reactive oxygen species

N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice

The Role of Physiological Vitamin C Concentrations on Key Functions of Neutrophils Isolated from Healthy Individuals

Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review

The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients

Vitamin D affects Covid-19 mortality

Perspective: Vitamin D deficiency and COVID-19 severity -plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis (R1)

Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19

High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET Formation

Mitochondria regulate neutrophil activation by generating ATP for autocrine purinergic signaling

The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis

Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury

Neutrophilspecific knockout demonstrates a role for mitochondria in regulating neutrophil motility in zebrafish

The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes

Production of oxygen-centered radicals by neutrophils and macrophages as studied by electron spin resonance (ESR)

Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice

Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression

Role of nrf2 in oxidative stress and toxicity

Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases

Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development

Nrf2 Activator PB125(®) as a Potential Therapeutic Agent against COVID-19

Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients

Can Activation of NRF2 Be a Strategy against COVID-19?